<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722485</url>
  </required_header>
  <id_info>
    <org_study_id>KCI.CLEANSE.CHOICE.2017.02</org_study_id>
    <nct_id>NCT03722485</nct_id>
  </id_info>
  <brief_title>Negative Pressure Wound Therapy With Instillation of Saline Solution Versus Collagenase Ointment in Full-thickness Wounds</brief_title>
  <acronym>ACCELERATE</acronym>
  <official_title>Hydromechanical Cleansing With V.A.C. VERAFLO CLEANSE CHOICE™ Dressing and NPWTi-d vs. Collagenase Ointment in the Management of Full-thickness Wounds</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KCI USA, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KCI USA, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of wound bed surface area containing clean, healthy viable tissue in&#xD;
      full-thickness wounds.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study evaluates changes in wound bed surface area of clean, healthy viable tissue in&#xD;
      subjects with full-thickness wounds using negative pressure wound therapy with instillation&#xD;
      of saline solution versus a collagenase ointment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 12, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Change in Wound Bed Surface Area (cm2)</measure>
    <time_frame>6-9 days of treatment</time_frame>
    <description>The percent change in the wound bed surface area (cm2) considered to be clean, healthy, and viable from baseline to Day 6-9 upon the final dressing removal.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent change in total wound volume (cm3)</measure>
    <time_frame>6-9 days of treatment</time_frame>
    <description>The percent change in total wound volume (cm3) from baseline to Day 6-9 upon the final dressing removal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent change in total wound area (cm2)</measure>
    <time_frame>6-9 days of treatment</time_frame>
    <description>The percent change in total wound area (cm2) from baseline to Day 6-9 upon the final dressing removal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physician assessment of need for debridement</measure>
    <time_frame>6-9 days of treatment</time_frame>
    <description>Physician assessment of the need for surgical debridement upon completion of study treatment up to Day 6-9.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Wounds and Injuries</condition>
  <condition>Wound Healing</condition>
  <condition>Granulation Tissue</condition>
  <arm_group>
    <arm_group_label>Negative Pressure Therapy w/ instillation and dwell (NPWTi-d)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>V.A.C. VeraFlo Cleanse Choice Dressing, V.A.C.Ulta Therapy Unit and saline solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagenase Ointment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Collagenase Ointment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Negative Pressure Therapy w/ instillation and dwell (NPWTi-d)</intervention_name>
    <description>Negative Pressure Therapy at -125mmHg for 3.5 hours followed by 10 minute dwell of saline solution for 6-9 days.</description>
    <arm_group_label>Negative Pressure Therapy w/ instillation and dwell (NPWTi-d)</arm_group_label>
    <other_name>V.A.C. VeraFlo Cleanse Choice</other_name>
    <other_name>V.A.C.Ulta Therapy Unit</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Collagenase Ointment</intervention_name>
    <description>Collagenase ointment applied daily to the wound and covered with secondary dressing for 6-9 days.</description>
    <arm_group_label>Collagenase Ointment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        The Subject:&#xD;
&#xD;
          1. is anticipated to be hospitalized for the duration of treatment (minimum of 6 days).&#xD;
&#xD;
          2. is ≥ 18 years of age.&#xD;
&#xD;
          3. or their legally authorized representative is able to provide informed consent.&#xD;
&#xD;
          4. has been diagnosed with a wound (eg, chronic, acute, traumatic, or dehisced wounds)&#xD;
             and/or ulcer (ie, full- thickness wounds) that meets the following criteria:&#xD;
&#xD;
               1. total surface area measuring ≥ 16 cm2, including a minimum width of 2 cm (before&#xD;
                  removal of eschar at the bedside and excluding undermining).&#xD;
&#xD;
               2. &lt; 20 cm across (edge-to-edge) at any point perpendicular to the wound edges.&#xD;
&#xD;
          5. has, in the opinion of the investigator, no more than 2/3 of the wound bed surface&#xD;
             area considered to be clean, healthy, and viable. If eschar is present at baseline, it&#xD;
             must be removed by bedside debridement prior to assessing the percentage of clean,&#xD;
             healthy, and viable wound bed.&#xD;
&#xD;
          6. has a negative urine or serum pregnancy test at screening (if female and has potential&#xD;
             for pregnancy) and is willing to take precautionary measures to prevent pregnancy&#xD;
             during the duration of the study (up to 9 days).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        The Subject:&#xD;
&#xD;
          1. has been diagnosed with malignancy in the wound.&#xD;
&#xD;
          2. has untreated osteomyelitis.&#xD;
&#xD;
          3. has an untreated systemic infection.&#xD;
&#xD;
          4. has active cellulitis in the periwound area.&#xD;
&#xD;
          5. has a known allergy or hypersensitivity to study materials: collagenase ointment,&#xD;
             dressing(s), and/or dressing components such as acrylic adhesives or polyurethane.&#xD;
&#xD;
          6. has, in the opinion of the investigator, a clinically significant condition that would&#xD;
             impair the Subject's ability to comply with the study procedures.&#xD;
&#xD;
          7. has had radiation directly to the wound area.&#xD;
&#xD;
          8. has been diagnosed with a major vascular deficit limiting arterial inflow to the wound&#xD;
             region, as determined by the Investigator's interpretation of the Subject's medical&#xD;
             history.&#xD;
&#xD;
          9. has eschar in the wound that cannot be removed by bedside sharp and/or mechanical&#xD;
             debridement.&#xD;
&#xD;
         10. is participating in another interventional clinical trial for the duration of the&#xD;
             study.&#xD;
&#xD;
         11. has unexplored fistulas in the wound or fistulas in the wound that connect to other&#xD;
             body cavities.&#xD;
&#xD;
         12. has a wound with any tunneling present.&#xD;
&#xD;
         13. has inadequate hemostasis at the wound site, as determined by the investigator.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Natalie Hernandez</last_name>
    <phone>210-515-4211</phone>
    <email>nhernandez7@mmm.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anthony Tate</last_name>
    <phone>210-515-4060</phone>
    <email>actate@mmm.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Banner-University Medical Center Phoenix</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Chickris</last_name>
      <email>chickris@arizona.edu</email>
    </contact>
    <contact_backup>
      <last_name>Patricia Teran, MS</last_name>
      <phone>602-255-7562</phone>
      <email>pteran@email.arizona.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Seach</last_name>
      <phone>520-626-8370</phone>
      <email>aseach@surgery.arizona.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medstar Georgetown University Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Pena</last_name>
      <phone>202-444-7288</phone>
      <email>Sebastian.Pena@gunet.georgetown.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amreen Barde</last_name>
      <phone>312-563-7519</phone>
      <email>Amreen_Barde@rush.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Shore Hospital Center for Wound Healing</name>
      <address>
        <city>Weymouth</city>
        <state>Massachusetts</state>
        <zip>02190</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maureen DeMenna</last_name>
      <phone>781-624-4369</phone>
      <email>MDemenna@southshorehealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Tessier</last_name>
      <phone>508-856-1729</phone>
      <email>Heather.Tessier@umassmed.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Missouri</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Randolph</last_name>
      <phone>573-882-4387</phone>
      <email>RandolphJL@health.missouri.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mercy</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Northwell Health System - North Shore University Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sally Kaplan</last_name>
      <phone>516-562-4578</phone>
      <email>Skaplan2@northwell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York University - Winthrop Hospital</name>
      <address>
        <city>Mineola</city>
        <state>New York</state>
        <zip>11501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Alsamarraie</last_name>
      <phone>516-663-1669</phone>
      <email>cindy.alsamarraie@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Helen Liu</last_name>
      <email>Helen.Liu@nyulangone.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoe Krebs</last_name>
      <phone>614-685-6374</phone>
      <email>Zoe.Krebs@osumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allegra Bermudez</last_name>
      <phone>610-217-1427</phone>
      <email>Allegra.Bermudez@jefferson.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15261</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 25, 2018</study_first_submitted>
  <study_first_submitted_qc>October 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2018</study_first_posted>
  <last_update_submitted>April 8, 2021</last_update_submitted>
  <last_update_submitted_qc>April 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

